Johnson & Johnson Expects 4 Cent Q1 EPS Hit From Venezuelan Currency Devaluation (JNJ)

Johnson & Johnson Expects 4 Cent Q1 EPS Hit From Venezuelan Currency Devaluation (JNJ)


Another company, health care products maker Johnson & Johnson (JNJ), said on Monday that the currency devaluation in Venezuela will have a negative impact on upcoming earnings.

The New Brunswick, New Jersey-based company said that it will take a charge of $100 million in the first quarter of 2013 as a result of Venezuela’s currency devaluation. This equates to a negative impact of 4 cents per share to first quarter EPS.

JNJ’s hefty charge is related to the re-measurement of the local balance sheet. Despite the charge and the negative impact it will have on first quarter earnings results, it is not expected to impact the company’s full year outlook which was previously announced in January.

Johnson & Johnson shares were relatively flat during pre-market trading on Monday. The stock is up +18.29% over the past year.

The Bottom Line
Shares of Johnson & Johnson (JNJ) have a dividend yield of 3.20% based on Friday’s closing price of $76.25 and the company’s annualized dividend payout of $2.44 per share.

Johnson & Johnson (JNJ) is recommended at this time, holding a DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today